Transversus Abdominis Plane Catheter Following Kidney Transplantation
Continuous Infusion of Local Anesthetic After Kidney Transplantation
This is a phase III, randomized, double-blinded, sham-controlled trial comparing the use of a continuous infusion of local anesthetic via transversus abdominis plane (TAP) catheter to a saline infusion (sham) via TAP catheter along with standard postoperative analgesia in patients undergoing kidney transplantation. Patients will have a TAP catheter placed at the time of kidney transplantation by the surgical team under direct vision. They are then randomized to a continuous infusion of local anesthetic or saline for 48 hours postoperatively. Both groups will receive a standard postoperative analgesic regimen including a Patient Controlled Analgesic (PCA) pump and multimodal analgesics including acetaminophen and gabapentin.
研究概览
研究类型
注册 (预期的)
阶段
- 第三阶段
联系人和位置
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male, female, non-binary gender, aged >18 years.
- Undergoing a kidney transplant (deceased or living donor) as treatment for stage 5 chronic kidney disease (Glomerular filtration rate < 15ml/min) either on dialysis, or approaching dialysis
- No history of allergy to any local anesthetic.
- Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration
Exclusion Criteria:
- Current use of opioid pain medications prior to kidney transplantation.
- Known allergic reactions to components of any local anesthetic medication.
- Prior local anesthetic systemic toxicity.
- History of chronic pain undergoing current active treatment for the same.
- Age <18 years (this analgesic approach has not been established in this population).
- Unable or unwilling to use IV PCA pump for any reason (manual dexterity, cognitive impairment, patient choice etc.).
- Multi-visceral transplantation.
- Incision other than standard Gibson incision.
- Unilateral or bilateral nephrectomy at time of kidney transplant.
- Advanced liver disease.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Local Anaesthetic Infusion
|
Ropivacaine infusion via transversus abdominis plane catheter.
|
|
假比较器:Saline Infusion
|
Saline infusion via transversus abdominis plane catheter.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Oral morphine equivalent (OME)
大体时间:48 hours post kidney transplantation
|
OME in mg
|
48 hours post kidney transplantation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Visual Analog Scale pain rating
大体时间:12, 24, and 48 hours post kidney transplantation
|
Series of 5 faces that depict discomfort levels ranging from severe pain (score 5) to no pain at all (score 1).
The higher the score, the more pain a patient has.
|
12, 24, and 48 hours post kidney transplantation
|
|
Patient quality of life score
大体时间:48 hours post kidney transplantation
|
48 hours post kidney transplantation
|
|
|
Time to return of bowel function postoperatively
大体时间:Duration of admission
|
Duration of admission
|
|
|
Incidence of local anesthetic systemic toxicity
大体时间:Duration of admission
|
Duration of admission
|
|
|
Postoperative adverse events (surgical)
大体时间:Duration of admission
|
Duration of admission
|
|
|
Delayed graft function
大体时间:Duration of admission
|
Defined as the requirement for hemodialysis/peritoneal dialysis within the first 7 days after kidney transplantation for any reason.
|
Duration of admission
|
|
Creatinine (mmol/L) at time of discharge
大体时间:Duration of admission
|
Duration of admission
|
|
|
Length of stay
大体时间:Duration of admission
|
Duration of admission
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.